153 related articles for article (PubMed ID: 23104305)
1. Osmotically regulated floating asymmetric membrane capsule for controlled site-specific delivery of ranitidine hydrochloride: optimization by central composite design.
Chauhan MS; Kumar A; Pathak K
AAPS PharmSciTech; 2012 Dec; 13(4):1492-501. PubMed ID: 23104305
[TBL] [Abstract][Full Text] [Related]
2. In Situ Phase-Transited Asymmetric Membrane Capsules: A Means for Achieving Delayed and Osmotic Release for pH Solubility-Dependant Drugs.
Philip AK; Philip B
PDA J Pharm Sci Technol; 2011; 65(1):32-41. PubMed ID: 21414938
[TBL] [Abstract][Full Text] [Related]
3. Asymmetric membrane capsules of phenylephrine hydrochloride: an osmotically controlled drug delivery system.
Kumar A; Philip AK; Pathak K
Curr Drug Deliv; 2011 Sep; 8(5):474-82. PubMed ID: 21696358
[TBL] [Abstract][Full Text] [Related]
4. Osmotic flow through asymmetric membrane: a means for controlled delivery of drugs with varying solubility.
Philip AK; Pathak K
AAPS PharmSciTech; 2006 Jul; 7(3):56. PubMed ID: 17025237
[TBL] [Abstract][Full Text] [Related]
5. Phase Transited Asymmetric Membrane Capsule: A Means for Achieving Delayed and Controlled Osmotic Flow.
Philip AK; Philip B
Curr Drug Deliv; 2010 Jul; 7(3):230-7. PubMed ID: 20497101
[TBL] [Abstract][Full Text] [Related]
6. Formulation and evaluation of floating tablet of H2-receptor antagonist.
Kesarla RS; Vora PA; Sridhar BK; Patel G; Omri A
Drug Dev Ind Pharm; 2015; 41(9):1499-511. PubMed ID: 25243639
[TBL] [Abstract][Full Text] [Related]
7. In situ-formed asymmetric membrane capsule for osmotic release of poorly water-soluble drug.
Philip A; Pathak K
PDA J Pharm Sci Technol; 2007; 61(1):24-36. PubMed ID: 17390701
[TBL] [Abstract][Full Text] [Related]
8. Statistical optimization of ranitidine HCl floating pulsatile delivery system for chronotherapy of nocturnal acid breakthrough.
Roy P; Shahiwala A
Eur J Pharm Sci; 2009 Jun; 37(3-4):363-9. PubMed ID: 19491027
[TBL] [Abstract][Full Text] [Related]
9. Phase transited and vapor-induced dual capsular system (DCS) for achieving delayed and osmotic release of cefadroxil.
Philip AK; Philip B
Pharm Dev Technol; 2011 Oct; 16(5):457-65. PubMed ID: 20482448
[TBL] [Abstract][Full Text] [Related]
10. Floating osmotic drug delivery system of ranitidine hydrochloride: development and evaluation--a technical note.
Kumar P; Singh S; Mishra B
AAPS PharmSciTech; 2008; 9(2):480-5. PubMed ID: 18431658
[No Abstract] [Full Text] [Related]
11. Asymmetric membrane capsule for osmotic delivery of flurbiprofen.
Choudhury PK; Ranawat MS; Pillai MK; Chauhan CS
Acta Pharm; 2007 Sep; 57(3):343-50. PubMed ID: 17878113
[TBL] [Abstract][Full Text] [Related]
12. Osmotically regulated flow of flurbiprofen through in situ formed asymmetric membrane capsule.
Philip AK
Curr Drug Deliv; 2008 Apr; 5(2):127-32. PubMed ID: 18393815
[TBL] [Abstract][Full Text] [Related]
13. A novel solubility-modulated granules through porosity osmotic pump for controlled carvedilol delivery.
Song QL; Li P; Li YM
Pharm Dev Technol; 2012; 17(6):666-76. PubMed ID: 21486184
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects.
Wang CY; Ho HO; Lin LH; Lin YK; Sheu MT
Int J Pharm; 2005 Jun; 297(1-2):89-97. PubMed ID: 15885936
[TBL] [Abstract][Full Text] [Related]
15. Experiment on formulation and drug release behavior of porosity asymmetric membrane capsules in vitro.
Fu HX; Li H; Zhang FZ; Zhao YZ; Wan CW; Chen MT; Jia XC; Yan L; Sun CC; Xu YY
Drug Dev Ind Pharm; 2012 Jun; 38(6):670-8. PubMed ID: 22469006
[TBL] [Abstract][Full Text] [Related]
16. A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system.
Yang Y; Zhao Z; Wang Y; Yang L; Liu D; Yang X; Pan W
Int J Pharm; 2016 Jun; 506(1-2):340-50. PubMed ID: 27132166
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric membrane in membrane capsules: a means for achieving delayed and osmotic flow of cefadroxil.
Philip AK; Pathak K; Shakya P
Eur J Pharm Biopharm; 2008 Jun; 69(2):658-66. PubMed ID: 18206358
[TBL] [Abstract][Full Text] [Related]
18. Chitosan/cellulose acetate microspheres preparation and ranitidine release in vitro.
Zhou HY; Chen XG; Liu CS; Meng XH; Yu LJ; Liu XY; Liu N
Pharm Dev Technol; 2005; 10(2):219-25. PubMed ID: 15926670
[TBL] [Abstract][Full Text] [Related]
19. Gastroretentive drug delivery system of Ranitidine hydrochloride based on osmotic technology: development and evaluation.
Kumar P; Singh S; Mishra B
Curr Drug Deliv; 2008 Oct; 5(4):332-42. PubMed ID: 18855605
[TBL] [Abstract][Full Text] [Related]
20. Floating elementary osmotic pump tablet (FEOPT) for controlled delivery of diethylcarbamazine citrate: a water-soluble drug.
Khan ZA; Tripathi R; Mishra B
AAPS PharmSciTech; 2011 Dec; 12(4):1312-23. PubMed ID: 21969244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
